Replies to post #170456 on Vivos Inc (RDGL)

[doccjc]

If you paid attention to the Twitter posts , you’d know there were 2 phases of testing and one phase of analysis .
We’ll see if tomorrow sheds some light as to where they are with phase 2 .

[kayak_wench]

There are two phases of genotoxicity testing (as noted in my post made over an hour before yours). We know that from the posts on X.
If you are not reading the companies posts to X you are not up to date. They have apparently decided that is their marketing tool (I'm not thrilled about that, as it requires an account and it pretty crappy site now) and this is where their non quarterly updates are going. I shouldn't have to tell anyone this, but you can't only read the posts you have to read the replies. Do a little DD.

On 1/25 they posted they completed phase 1

Another update and another step that was taken during the fourth quarter #cancertherapy #newgenerationtherapy #genotoxicity #radiogel #isopet #innovations #cancer $RDGL pic.twitter.com/alvoqEDpXS

— Vivos Inc. (@VivosIncUSA) January 25, 2024

Then later that day clarified there were two phases

Two phases of testing, one phase of analysis, we are doing what is required and will update on the progress, stay tuned!

— Vivos Inc. (@VivosIncUSA) January 25, 2024

Follow the thread and you will see they never say when the second phase will occur despite being clearly asked. They just repeat the same story of we will keep you informed.

As I noted before, I believe they either don't know when they can get the second phase of testing done or they know it will take a long time and don't want to tell us.
It is most likely to be the former. Not just anyone can do genotoxicity testing. They have to find the experts that can do the testing and get on that companies calendar. Whatever the reason, taking the approach of avoiding giving an answer to a question any investor would want answered is stupid, diengienious, and detrimental to the investors interests.